Autres langues MedMira Inc. OTC Markets

Actions

MMIRF

CA58501R1029

Marché Fermé - OTC Markets Autres places de cotation 21:39:42 21/06/2024			Varia. 5j.	Varia. 1 janv.
0,0866 ^USD	+561,07 %		0,00 %	+29,45 %

02/04	MedMira Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 janvier 2024	CI
27/03	Samsung Pay ne fonctionnera plus avec le système de paiement russe Mir à partir du 3 avril	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

MedMira Inc.: MedMira gibt Einstellung eines Vizepräsidenten für Geschäftsentwicklung bekannt	01/05
MedMira Inc.: MedMira Announces the Hire of Vice President of Business Development	01/05
MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	02/04
Samsung Pay to stop working with Russia's Mir payment system from April 3	27/03
MedMira Inc.: MedMira erhält kanadisches Patent für sein einzigartiges quantitatives Diagnosesystem	14/03
MedMira Says Received Canadian Patent for its Quantitative Diagnostic System	13/03
MedMira Brief: Says Received Canadian Patent for its Quantitative Diagnostic System	13/03
MedMira Inc.: MedMira gibt Unternehmens-Update zur klinischen Bewertung von MedMiras Produkten	05/02
MedMira's Fiscal Q1 Loss Widens, Revenue Drops	02/01
MedMira Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	29/12
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test	14/12
MedMira Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	28/11
Medmira Inc. Provides Update on Its Progress to Achieve Regulatory Approval in Canada and the USA for Its Infectious Disease Rapid Tests	28/09/23
Canadian Investment Regulatory Organization Trade Resumption - MIR	31/08/23
Canadian Investment Regulatory Organization Trading Halt - MIR	29/08/23
MedMira's Fiscal Q3 Loss Widens, Revenue Falls	30/06/23
MedMira Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	29/06/23
MedMira Falls Near 17% As Widens Q2 Net Loss YOY	04/04/23
MedMira Widens Q2 Net Loss YOY	04/04/23
MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	03/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues MedMira Inc. OTC Markets

Actions

MMIRF

CA58501R1029

Autres langues

Filtres